Literature DB >> 25389076

Cohort study of corticosteroid use and risk of hospital admission for diverticular disease.

F Hjern1, M W Mahmood, M Abraham-Nordling, A Wolk, N Håkansson.   

Abstract

BACKGROUND: Medication has been suggested as a potential risk factor for diverticular disease. The objective of this study was to investigate the association between the intake of corticosteroids, indometacin or aspirin and diverticular disease.
METHOD: This was a prospective population-based cohort study of middle-aged women in the Swedish Mammography Cohort. Use of corticosteroids (oral or inhaled), indometacin or aspirin in 1997 was determined from questionnaires. Cases of diverticular disease were identified from the Swedish national registers until the end of 2010. The relative risk (RR) of diverticular disease requiring hospital admission according to the use of medication was estimated using Cox proportional hazards models, adjusted for age, body mass index, physical activity, fibre intake, diabetes, hypertension, alcohol, smoking and education.
RESULTS: A total of 36 586 middle-aged women in the Swedish Mammography Cohort were included, of whom 674 (1.8 per cent) were hospitalized with diverticular disease at least once. Some 7.2 per cent of women reported intake of oral corticosteroids and 8.5 per cent use of inhaled corticosteroids. In multivariable analysis, women who reported oral corticosteroid intake had a 37 per cent (RR 1.37, 95 per cent c.i. 1.06 to 1.78; P = 0.012) increased risk of diverticular disease compared with those who reported no intake at all. Use of inhaled corticosteroids was associated with an even more pronounced increase in risk of 71 per cent (RR 1.71, 1.36 to 2.14; P < 0.001). There was a significant dose-response relationship, with the risk increasing with longer duration of inhaled corticosteroids (P for trend < 0.001). Use of indometacin (2.5 per cent of women) or aspirin (44.2 per cent) did not influence the risk.
CONCLUSION: There was a significant relationship between corticosteroids (especially inhaled) and diverticular disease requiring hospital admission.
© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25389076     DOI: 10.1002/bjs.9686

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

Review 1.  The genetic epidemiology of diverticulosis and diverticular disease: Emerging evidence.

Authors:  Matthias C Reichert; Frank Lammert
Journal:  United European Gastroenterol J       Date:  2015-10       Impact factor: 4.623

Review 2.  Complicated Diverticular Disease.

Authors:  Kathleen M Coakley; Bradley R Davis; Kevin R Kasten
Journal:  Clin Colon Rectal Surg       Date:  2020-10-21

3.  Assessment of risk for recurrent diverticulitis: a proposal of risk score for complicated recurrence.

Authors:  Ville Sallinen; Juha Mali; Ari Leppäniemi; Panu Mentula
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

4.  Socioeconomic characteristics and comorbidities of diverticular disease in Sweden 1997-2012.

Authors:  Maziar Nikberg; Jianguang Ji; Jerzy Leppert; Kristina Sundquist; Abbas Chabok
Journal:  Int J Colorectal Dis       Date:  2017-08-07       Impact factor: 2.571

5.  Alpha-1-antitrypsin deficiency (carrier) as possible risk factor for development of colonic diverticula. A multicentre prospective case-control study: the ALADDIN study.

Authors:  S J Rottier; L C Dreuning; J van Pelt; A A W van Geloven; X D Y Beele; P M Huisman; W Y Deurholt; C A Rottier; K van Leeuwen; M de Boer; G van Mierlo; M A Boermeester; W H Schreurs
Journal:  Colorectal Dis       Date:  2020-09-01       Impact factor: 3.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.